Compile Data Set for Download or QSAR
maximum 50k data
Found 69 Enz. Inhib. hit(s) with Target = 'Synaptic vesicle glycoprotein 2A'
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582018(US11518754, Compound (R)-3)
Affinity DataKi:  0.270nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582020(US11518754, Compound (R)-5)
Affinity DataKi:  0.580nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582019(US11518754, Compound (R)-4)
Affinity DataKi:  2.08nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582022(US11518754, Compound (R)-12)
Affinity DataKi:  4.43nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582021(US11518754, Compound (R)-11)
Affinity DataKi:  4.44nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582027(US11518754, Compound (S)-12)
Affinity DataKi:  4.66nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582024(US11518754, Compound (S)-4)
Affinity DataKi:  9.43nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582023(US11518754, Compound (S)-3)
Affinity DataKi:  12.5nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582026(US11518754, Compound (S)-11)
Affinity DataKi:  18.2nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582025(US11518754, Compound (S)-5)
Affinity DataKi:  115nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Mus musculus)
Jagiellonian University Medical College

Curated by ChEMBL
LigandPNGBDBM50592917(CHEMBL5185567)
Affinity DataKi: >2.50E+5nMAssay Description:Binding affinity to mouse SV2A in presence of levetiracetam by radioligand binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSynaptic vesicle glycoprotein 2A(Homo sapiens)
Jagiellonian University Medical College

Curated by ChEMBL
LigandPNGBDBM50592916(CHEMBL5206486)
Affinity DataKi: >2.50E+5nMAssay Description:Binding affinity to human SV2A in presence of levetiracetam by radioligand binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSynaptic vesicle glycoprotein 2A(Mus musculus)
Jagiellonian University Medical College

Curated by ChEMBL
LigandPNGBDBM50592916(CHEMBL5206486)
Affinity DataKi: >2.50E+5nMAssay Description:Binding affinity to mouse SV2A in presence of levetiracetam by radioligand binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSynaptic vesicle glycoprotein 2A(Homo sapiens)
Jagiellonian University Medical College

Curated by ChEMBL
LigandPNGBDBM50592917(CHEMBL5185567)
Affinity DataKi: >2.50E+5nMAssay Description:Binding affinity to human SV2A in presence of levetiracetam by radioligand binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582018(US11518754, Compound (R)-3)
Affinity DataIC50:  1.62nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582020(US11518754, Compound (R)-5)
Affinity DataIC50:  3.52nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582019(US11518754, Compound (R)-4)
Affinity DataIC50:  12.6nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582022(US11518754, Compound (R)-12)
Affinity DataIC50:  26.8nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582021(US11518754, Compound (R)-11)
Affinity DataIC50:  26.9nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582027(US11518754, Compound (S)-12)
Affinity DataIC50:  28.2nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582024(US11518754, Compound (S)-4)
Affinity DataIC50:  57nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582023(US11518754, Compound (S)-3)
Affinity DataIC50:  75.6nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422558(CHEMBL434705)
Affinity DataIC50:  79.4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422517(CHEMBL149348)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422531(BRIVARACETAM | UCB-34714)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582026(US11518754, Compound (S)-11)
Affinity DataIC50:  109nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422518(CHEMBL358242)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422548(CHEMBL150241)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422525(CHEMBL348187)
Affinity DataIC50:  158nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422519(CHEMBL358393)
Affinity DataIC50:  199nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422540(CHEMBL152911)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422522(CHEMBL347071)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422533(CHEMBL150331)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422526(CHEMBL359062)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422556(CHEMBL358161)
Affinity DataIC50:  501nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM582025(US11518754, Compound (S)-5)
Affinity DataIC50:  698nMAssay Description:For competition binding experiments, 0.5 mg of the rat brain homogenates in 800 μL of binding buffer (2 mM MgCl2 in 50 mM Tris*HCl, pH=7.4) were...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422542(Keppra | Keppra Xr | LEVETIRACETAM | Levetiracetam...)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422523(CHEMBL358239)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422544(CHEMBL154983)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422545(CHEMBL345318)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422555(CHEMBL346223)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422541(CHEMBL149400)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422536(CHEMBL421785)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422549(CHEMBL150791)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422543(CHEMBL153264)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422534(CHEMBL153282)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422553(CHEMBL151650)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422551(CHEMBL358877)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422532(CHEMBL150281)
Affinity DataIC50:  2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Yale University

US Patent
LigandPNGBDBM50422552(CHEMBL153690)
Affinity DataIC50:  2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 69 total ) | Next | Last >>
Jump to: